Protocol for differentiating hematopoietic progenitor cells from human pluripotent stem cells in chemically defined monolayer culture
DOI: 10.1016/j.xpro.2024.103545
Authors: Shaokang Mo; Kengyuan Qu; Jun Shen; Kuangyu Yen
Step 1: iPSC/ESC maintainance
day 0 ~ 1
culture “adherent” human cell in “E8” for “1” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| Y27632 | 1.0e-5 | mol/l |
Ideally, “dummy” should express “TRA-1-81”, “SSEA4” at the end of culture.
Step 2: mesoderm 1
day 1 ~ 3
culture “adherent” unknown species cell in “APEL 2 medium” for “2” days. For ECM, use “vitronectin” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “2” days.
| concentration | unit | |
|---|---|---|
| PFHM-II | 4.76 | % |
| Activin A | 4.0e-6 | g/l |
| BMP4 | 1.0e-5 | g/l |
| CHIR90021 | 3.0e-6 | mol/l |
| Y27632 | 1.0e-5 | mol/l |
Ideally, “mesoderm” should express “TBXT” at the end of culture.
Step 3: endothelial 1
day 3 ~ 4
culture “adherent” unknown species cell in “APEL 2 medium” for “1” days. For ECM, use “vitronectin” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| PFHM-II | 4.76 | % |
| VEGF | 4.0e-5 | g/l |
Ideally, “EC” should be obtained at the end of culture.
Step 4: endothelial 2
day 4 ~ 5
culture “adherent” unknown species cell in “APEL 2 medium” for “1” days. For ECM, use “vitronectin” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| PFHM-II | 4.76 | % |
| VEGF | 4.0e-5 | g/l |
| FGF | 4.0e-5 | g/l |
Ideally, “EC” should express “CD34”, “CDH5” at the end of culture.